|

ZG005 Powder for Injection Clinical Trials

3 actively recruiting trials

Also known as: ZG005

Pipeline

Phase 1/2: 3

Top Sponsors

  • Suzhou Zelgen Biopharmaceuticals Co.,Ltd3

Indications

  • Cancer3
  • Solid Tumors1
  • Solid Tumor1
  • Cervical Carcinoma1

Other3 trials

A Study of ZG005 Combined With Donafenib in Patients With Advanced Solid Tumor
Phase 1/2
A Study of ZG005 in Patients With Advanced Solid Tumors
Phase 1/2
Study of ZG005 in Combination With Paclitaxel＋Platinum-based ± Bevacizumab in Patients With Advanced Cervical Carcinoma
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.